Below are the communications policies for Complex Coronary Summit 2027, including how to handle embargoes and news releases, as well as suggested language for coverage of the event.
Media, investigators, organizations issuing press releases, and others with access to research accepted for presentation during Complex Coronary Summit 2027 are required to abide by the embargo policies governing CRF® meetings.
The Cardiovascular Research Foundation® embargoes information presented as a late-breaking clinical trial, late-breaking clinical science, or featured clinical research. Coverage of these studies is strictly prohibited until the start time of each trial’s official presentation as listed in the Complex Coronary Summit Program on the official Complex Coronary Summit website. No journalist, exhibitor, or university (or affiliated organization or company) may disseminate information until the trial’s official presentation time. All embargo times are listed in Eastern Standard Time (EST). There is no official embargo for research presented as an abstract, challenging case, or during an innovation session. However, to maximize the impact of your presentation we recommend that no data be shared until the start of Complex Coronary Summit 2027 and ideally not before your formal presentation.
For questions regarding the embargo policy, please email [email protected].
Press releases announcing activities and/or research at Complex Coronary Summit 2027 must adhere to the following guidelines:
- All news releases must comply with the CRF embargo policy.
- Releases must include a reference to Complex Coronary Summit 2027 in the body, preferably in the first paragraph. Suggested language is provided below.
- Suggested language: “… presented at Complex Coronary Summit 2027, the annual conference organized by the Cardiovascular Research Foundation® (CRF)”
- A copy of the press release, or draft press release, must be submitted in advance for review and approval. Please email the press release to the contact below. All submissions will be treated with strict confidentiality.
- Releases must not imply that CRF endorses any product or service.
- Releases must not be scientifically misleading or ethically questionable.
CRF® Press Office Contact
Judy Romero
646.434.4608
[email protected]
These policies were last updated January 6, 2026 and are subject to change. Please check with the CRF Press Office for further updates.

